Johnson & Johnson

By Jonah Comstock February 13, 2017
Big Health has hired Kelvin Kwong, former director of product management at Jawbone, to be its vice president of product management. Big Health is currently focused on the sleep space with its app Sleepio, so it makes sense to hire a Jawbone vet -- the tracker company invested quite a bit in sleep tracking before its recent pivot toward medical devices.  Big Heath also announced the hire on Dr....
By Heather Mack January 19, 2017
The US Food and Drug Administration has given the green light for a non-prescription version of BlueStar, WellDoc’s mobile diabetes management platform. Through this 510(k) class II clearance, WellDoc will now offer BlueStar and BlueStar Rx, allowing the company to offer the product through more channels. Both versions analyze diabetes data entered by the patient, comparing past data trends to...
By Jonah Comstock January 6, 2017
In addition to the many device launches, several digital health companies use CES (formerly known as the Consumer Electronic Show) in Las Vegas as an opportunity to announce updates and major partnerships and collaborations. Read on for the biggest non-launch health news from the show. Lots of news from Fitbit Wearable giant Fitbit announced a number of partnerships as well as updates to its app...
By Heather Mack January 4, 2017
Boston-based Rest Devices has announced a collaboration with Johnson & Johnson to develop a smart, personalized sleep coaching system for babies (and their parents, hovering over their crib with a smartphone). The offering, which consists of a wearable baby monitor called Mimo and a companion app called Nod, was announced during the Consumer Electronics Show in Las Vegas this week. The...
By Heather Mack December 19, 2016
The FDA has cleared the wireless integration of one of Johnson and Johnson subsidiary LifeScan’s blood glucose monitoring systems and WellDoc’s digital diabetes management platform for people with type 2 diabetes. The two companies originally teamed up in March of this year. The integrated system consists of OneTouch Verio Flex, LifeScan’s Bluetooth smart blood glucose monitoring system and...
By Jonah Comstock October 4, 2016
Following prompting from security and IT firm Rapid7, Johnson & Johnson, through its subsidiary Animas, has reached out to users of the Animas OneTouch Ping Insulin Infusion Pump to inform them about security vulnerabilities and how to mitigate them. According to Rapid7, because the communication with the insulin pump is not encrypted, an attacker could theoretically trigger unauthorized...
By Jonah Comstock September 14, 2016
The partnership announced in March between Johnson & Johnson subsidiary LifeScan and diabetes management company WellDoc has entered a new stage with a commercial partnership agreement, the companies announced yesterday.  "We’ve made considerable progress in our important relationship with LifeScan, Inc., which began earlier this year via a development agreement and a Johnson & Johnson...
By Heather Mack August 25, 2016
Ethicon, a medical device subsidiary of Johnson & Johnson, is collaborating with healthcare technology platform developer Touch Surgery to offer professionals a simulated surgical training program in the form of a free mobile app. The app, which is available on iOS, takes users through a variety of more than 75 simulated surgical procedures. With realistic 3D rendering, the user can cut,...
By Aditi Pai March 23, 2016
PatientsLikeMe has hired Joy Morel as the company’s SVP of Marketing, Patient Engagement and Business Intelligence. Morel previously worked for Verisign, where she was the senior director of global branding, advertising and creative services. She has also worked for TomTom/Tele Atlas and AOL. Morel will report to Michael Evers, who was recently promoted to EVP of marketing, technology, and...
By Aditi Pai March 1, 2016
Baltimore, Maryland-based WellDoc has announced a collaboration with LifeScan, a Johnson and Johnson company that makes blood glucose meters. WellDoc also raised an additional $7.5 million from Johnson & Johnson Innovation and other investors, bringing the company’s total funding in its most recent round to $29.5 million.  Existing investors include Samsung Ventures, Merck Global Health...